2L
22NW LP’s Anebulo Pharmaceuticals ANEB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $22.3M | Hold |
15,467,300
| – | – | 14.03% | 3 |
|
|
2025
Q1 | $20.1M | Hold |
15,467,300
| – | – | 13.49% | 3 |
|
|
2024
Q4 | $26M | Buy |
15,467,300
+10,101,010
| +188% | +$17M | 16.39% | 3 |
|
|
2024
Q3 | $10.4M | Hold |
5,366,290
| – | – | 8.68% | 5 |
|
|
2024
Q2 | $14.6M | Hold |
5,366,290
| – | – | 12.5% | 3 |
|
|
2024
Q1 | $15.4M | Hold |
5,366,290
| – | – | 13.27% | 2 |
|
|
2023
Q4 | $13M | Buy |
5,366,290
+300,000
| +6% | +$726K | 8.46% | 4 |
|
|
2023
Q3 | $15.5M | Hold |
5,066,290
| – | – | 11.03% | 4 |
|
|
2023
Q2 | $11.9M | Hold |
5,066,290
| – | – | 7.44% | 6 |
|
|
2023
Q1 | $14.7M | Hold |
5,066,290
| – | – | 9.03% | 4 |
|
|
2022
Q4 | $12.3M | Hold |
5,066,290
| – | – | 6.63% | 5 |
|
|
2022
Q3 | $14.2M | Buy |
5,066,290
+1,703,577
| +51% | +$4.77M | 8.02% | 4 |
|
|
2022
Q2 | $17.5M | Hold |
3,362,713
| – | – | 9.28% | 2 |
|
|
2022
Q1 | $23.8M | Hold |
3,362,713
| – | – | 8.64% | 1 |
|
|
2021
Q4 | $20.7M | Buy |
3,362,713
+19,148
| +0.6% | +$118K | 6.4% | 5 |
|
|
2021
Q3 | $21.9M | Hold |
3,343,565
| – | – | 6.52% | 3 |
|
|
2021
Q2 | $22.8M | Buy |
+3,343,565
| New | +$22.8M | 6.13% | 3 |
|